The role of cyclosporin in the treatment of severe myasthenia: a clinical study of 51 patients
About 1520% of myasthenic patients are refractory to standardsteroid therapy. The present study was aimed at evaluation ofefficacy and analysis of the algorithm of use of a novel immunosuppressantof natural origin, cyclosporine A, in the treatment ofsevere refractory forms of myasthenia gravis. In t...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Research Center of Neurology
2017-02-01
|
| Series: | Анналы клинической и экспериментальной неврологии |
| Subjects: | |
| Online Access: | https://annaly-nevrologii.com/journal/pathID/article/viewFile/242/66 |